Dna X (SONM) Equity Average (2019 - 2025)
Historic Equity Average for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to -$1.0 million.
- Dna X's Equity Average fell 10619.99% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 10619.99%. This contributed to the annual value of $8.3 million for FY2024, which is 6070.07% down from last year.
- Latest data reveals that Dna X reported Equity Average of -$1.0 million as of Q3 2025, which was down 10619.99% from -$1.2 million recorded in Q2 2025.
- In the past 5 years, Dna X's Equity Average ranged from a high of $23.9 million in Q1 2021 and a low of -$3.4 million during Q1 2025
- For the 5-year period, Dna X's Equity Average averaged around $14.1 million, with its median value being $16.2 million (2021).
- As far as peak fluctuations go, Dna X's Equity Average skyrocketed by 13479.18% in 2023, and later crashed by 11606.13% in 2025.
- Over the past 5 years, Dna X's Equity Average (Quarter) stood at $15.6 million in 2021, then soared by 30.19% to $20.4 million in 2022, then increased by 11.7% to $22.7 million in 2023, then tumbled by 78.78% to $4.8 million in 2024, then crashed by 121.09% to -$1.0 million in 2025.
- Its Equity Average stands at -$1.0 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$3.4 million for Q1 2025.